By expressing exogenous mutant GNAS in a tetracycline-controlled manner in established KRAS-mutant tumors, Ideno et al. [140] and Patra and coworkers [141] were able to delineate the specific functions of GNAS in tumor cell differentiation and cancer maintenance. The gene discussed is KRAS; the disease is cancer.